Tempus AI Diagnostics CEO Thomas Edward Schoenherr reports $188,580 Tempus AI common share sale
TEM•Source note
- Tempus AI Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002113721-26-000016), on August 25, 2026.
Insider transaction summary
- Tempus AI Diagnostics CEO Thomas Edward Schoenherr bought 2,694 shares of Class A common stock on Aug. 21, 2026.
- Purchase price: USD 70 per share.
- Direct holdings rose to 87,021 shares.
